Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Suspended 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Melanoma 65Kidney Neoplasms 24Carcinoma, Renal Cell 23Neoplasm Metastasis 20Breast Neoplasms 16Skin Neoplasms 14Ovarian Neoplasms 11Pancreatic Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Neoplasms 7Uterine Cervical Neoplasms 6Neuroblastoma 6Lymphoma 6Leukemia, Myeloid, Acute 6Leukemia 6Colorectal Neoplasms 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Non-Hodgkin 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Lung Neoplasms 5Colonic Neoplasms 5Urogenital Neoplasms 4Leukemia, Lymphocytic, Chronic, B-Cell 4Carcinoma, Ovarian Epithelial 4Burkitt Lymphoma 4Sezary Syndrome 3Rectal Neoplasms 3Mycosis Fungoides 3

Interventions

Temozolomide 22Radiotherapy 17Carmustine 9Magnetic Resonance Spectroscopy 8Carboplatin 8Vorinostat 6Surgical Procedures, Operative 6Radiation 6Cisplatin 6Chemotherapy, Adjuvant 6O(6)-benzylguanine 5Erlotinib Hydrochloride 5Cyclophosphamide 5Bevacizumab 5veliparib 4Vincristine 4Thiotepa 4Specimen Handling 4Radiotherapy, Intensity-Modulated 4Peripheral Blood Stem Cell Transplantation 4Methotrexate 4Lenalidomide 4Filgrastim 42,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 4Radiotherapy, Conformal 3Procarbazine 3Lomustine 3Iodine-125 3Immunoglobulin G 3Etoposide 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Astrocytoma × aldesleukin × Clear all
NCT00003067 2009-02-09

Biological Therapy in Treating Patients With Primary or Advanced Glioma

National Cancer Institute (NCI)

Phase 2 Suspended
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡